Top Five MRI Content of 2024

News
Slideshow

Catch up on the most well-viewed magnetic resonance imaging (MRI) content from 2024.

As we come to the end of 2024, we take a look back at the most well-read magnetic resonance imaging (MRI) imaging content with topics ranging from advanced neuroimaging for high-grade gliomas to the potential of MRI for active surveillance decisions for patients with intermediate risk prostate cancer. Review the slideshow below to see highlighted MRI content from the past year.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Related Content
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

Jeff Hall
May 16th 2025
Article

For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

Study Questions Utility of Ultrafast Breast MRI for Challenging Lesions and Moderate/Marked BPE

Study Questions Utility of Ultrafast Breast MRI for Challenging Lesions and Moderate/Marked BPE

Jeff Hall
May 9th 2025
Article

New research findings suggest that image quality and lesion conspicuity are significantly lower with ultrafast breast MRI in comparison to standard dynamic contrast-enhanced breast MRI.

The Reading Room: Potential fMRI Alternative -- fPACT

The Reading Room: Potential fMRI Alternative -- fPACT

Whitney J. Palmer
June 23rd 2021
Podcast

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging

Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging

Jeff Hall
May 7th 2025
Article

For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.

MRI Study Shows Impact of Gross Total Resection on Survival of Patients with IDH Wild-Type Glioblastoma

MRI Study Shows Impact of Gross Total Resection on Survival of Patients with IDH Wild-Type Glioblastoma

Jeff Hall
May 7th 2025
Article

Irrespective of age or O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status, gross total resection of IDH wild-type glioblastomas was associated with a median overall survival of 32.6 months, according to new MRI research.

© 2025 MJH Life Sciences

All rights reserved.